Chemfab Alkalis files FY26 annual report with ₹7.51 crore profit
Chemfab Alkalis Limited filed its FY26 annual report, showing consolidated revenue of ₹2,885.6 crore and PAT of ₹7.51 crore. The company completed key investments in electrolyser modernisation and OPVC pipe capacity expansion, positioning itself for growth in FY27 as government water infrastructure funding resumes.

*this image is generated using AI for illustrative purposes only.
Chemfab Alkalis Limited has submitted its annual report for the financial year ended March 31, 2026, to the stock exchanges. The filing provides a comprehensive overview of the company’s performance across its chlor-alkali and OPVC pipes segments during a year characterised by soft global caustic soda prices and paused government funding for water infrastructure projects.
Financial Performance in FY26
Consolidated revenue from operations stood at ₹2,885.6 crore in FY26, down from ₹3,220.9 crore in FY25. Profit after tax (PAT) declined to ₹7.51 crore from ₹15.22 crore in the previous year. Operational EBITDA was ₹36.70 crore, reflecting an EBITDA margin of 12.72%.
The chlor-alkali segment reported revenue of ₹1,956.9 crore, broadly stable compared to ₹1,906.4 crore in FY25. The segment recorded an EBIT loss of ₹1.17 crore, a significant improvement from the ₹5.20 crore loss in FY25, driven by recovering realisations in the second half of the year and contributions from the modernised plant.
The OPVC pipes segment saw revenue decline to ₹934.7 crore from ₹1,314.5 crore in FY25, primarily due to the pause in Jal Jeevan Mission funding between October 2024 and March 2026. Despite the revenue drop, the division remained profitable with an EBIT of ₹19.43 crore.
Capacity Expansion and Modernisation
During FY26, Chemfab Alkalis completed major capital projects across both business divisions. In the chlor-alkali segment, the company commissioned a new-generation electrolyser plant in November 2025, replacing the system installed in 1994. This technology modernisation programme, costing ₹56 crore, is expected to materially lower energy consumption and improve automation.
Additionally, a hybrid renewable energy project, structured through a dedicated special purpose vehicle, stands ready and awaits final transmission line clearances. Supply is expected to commence from Q1 FY27, after which renewable sources will meet close to 55% of the company’s energy needs.
In the OPVC pipes segment, Lines 5 and 6 were commissioned during the year, increasing capacity from 14,000 TPA to 20,000 TPA. Line 7 is scheduled to complete the Sri City site at 23,000 TPA in FY27. The company is now approved in 15 states for public water supply schemes, including Bihar and Gujarat added during FY26.
Outlook for FY27
Management expects FY27 to be materially stronger than FY26. The approval of Jal Jeevan Mission 2.0 with an allocation of ₹67,600 crore for FY27 is expected to restore the funding pipeline for rural water infrastructure, with meaningful disbursements anticipated from Q2 FY27. In the chlor-alkali segment, stabilising realisations, efficiencies from the modernised facility, and the commencement of hybrid power supply are expected to drive improved profitability.
Corporate Governance and Dividend
The Board recommended a final dividend of ₹1.25 per equity share, representing a payout rate of 12.50% on the face value of ₹10. The 17th Annual General Meeting is scheduled for September 9, 2026. Key agenda items include the reappointment of Suresh Krishnamurthi Rao as director and the appointment of M/s. M S K C & Associates LLP as statutory auditors for a five-year term.
What the Numbers Show
The divergence between the chlor-alkali and OPVC segments highlights the distinct cyclical drivers affecting each business. While the chlor-alkali segment benefited from cost efficiencies and recovering prices, the OPVC segment faced demand headwinds due to regulatory funding delays. However, the completion of capacity expansions positions the company to capture growth when government funding resumes, particularly given its leadership position in the OPVC market with the widest product range in India.
Historical Stock Returns for Chemfab Alkalis
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.35% | -0.56% | -1.06% | -3.45% | -46.31% | +127.99% |
How will the commencement of the hybrid renewable energy supply in Q1 FY27 impact Chemfab Alkalis' long-term cost structure and margin stability in the chlor-alkali segment?
Given the ₹67,600 crore allocation for Jal Jeevan Mission 2.0, what is the expected timeline for order book normalization in the OPVC pipes segment following the funding pause?
Will the newly commissioned 20,000 TPA capacity in the OPVC segment be sufficient to meet anticipated demand spikes, or does Chemfab need further expansion to maintain its market leadership?

































